Talk:Opening and Closing to Barney: First Things First 2001 VHS/@comment-2604:2000:1343:C444:CD1B:34A6:B0F:1313-20190131145258



Sr

=You could get HUMIRA for as little as $3.07*=
 * HOME
 * LEARN ABOUT HUMIRA
 * STARTING HUMIRA
 * CONTINUE TREATMENT

Whether you're first starting HUMIRA or have been taking it for some time, you may be wondering, "How can I reduce my out-of-pocket cost?"

For eligible patients, the HUMIRA Complete Savings Card may help you get HUMIRA for as little as $5 a month, every month.*

If your pharmacy is unable to process your HUMIRA Complete Savings Card for instant savings, you may still be able to get HUMIRA for as little as $5 a month by receiving a rebate for the amount you paid out of pocket for your prescription. Simply call 1.800.4HUMIRA  (1.800.448.6472) and speak to one of our Insurance Specialists to see if this option is right for you.

Savings apply whether you take HUMIRAundefinedalone or, for rheumatology patients, HUMIRA plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Please call 1.800.4HUMIRA (1.800.448.6472) for details.

All trademarks are properties of their respective companies.

Enroll in HUMIRA Complete to get your HUMIRA Complete Savings Card.

[https://www.humira.com/humira-complete/sign-up/savings-card Sign Up for HUMIRA Complete It just takes a minute or two.]

'''Need help now? Call''' 1.800.4HUMIRA (1.800.448.6472).

Already enrolled? Just enter your email address for access to most resources.


 * Terms and Conditions apply. This benefit covers HUMIRA® (adalimumab) alone or, for rheumatology patients, HUMIRA plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eligibility: Available to patients with commercial prescription insurance coverage for HUMIRA who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the HUMIRA Complete Savings card and patient must call HUMIRA Complete at 1-800-4HUMIRA to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the HUMIRA Complete Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions.

Arava® and Plaquenil® are registered trademarks of their respective owners.

Your savings card is always where you need it.
Once you get your HUMIRA Complete Savings Card, it’s always available to you right here. Just log in with your email address and you can access your card whenever—and wherever—you need it.

Because your card may help you save on every HUMIRA prescription you fill, it helps to always know where it is. Also, if you change jobs or insurance providers in the future, you'll want to present it—along with your insurance card—and ask your pharmacist for the savings benefit.

Savings on HUMIRA are available.
No matter your financial or job status, there may be ways to lower the amount you pay for HUMIRA. The first step is determining your current status. You may fall into one of these categories.
 * Terms and Conditions apply. This benefit covers HUMIRA® (adalimumab) alone or, for rheumatology patients, HUMIRA plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eligibility: Available to patients with commercial prescription insurance coverage for HUMIRA who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the HUMIRA Complete Savings card and patient must call HUMIRA Complete at 1-800-4HUMIRA to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the HUMIRA Complete Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. Please see full Terms and Conditions.

Arava® and Plaquenil® are registered trademarks of their respective owners.

†Eligibility restrictions apply. Eligibility determined by Medicare; not eligible for assistance with HUMIRA Complete Savings Card.

Having trouble using the HUMIRA Complete Savings Card at your pharmacy? Prescription rebates may be an option.
If your pharmacy does not accept the HUMIRA Complete Savings Card or you’re no longer able to use it to receive instant savings at the pharmacy, you may still be able to get HUMIRA for as little as $5 a month using the HUMIRA Complete Prescription Rebate‡. Simply call 1.800.4HUMIRA (1.800.448.6472) and speak to one of our Insurance Specialists to see if this option is right for you.

HUMIRA Complete offers three ways to submit your HUMIRA prescription receipts for a rebate for your out-of-pocket costs after you’ve paid for your prescription:

Online

 * Click here to submit your receipts for reimbursement electronically

Rebate Forms

 * Request paper forms to submit your Rx receipts for reimbursement by calling 1.800.4HUMIRA(1.800.448.6472)

App

 * Download the HUMIRA Complete App to submit receipts for reimbursement directly from your phone

You should receive your rebate check from Opus Health in approximately 5 business days.

AbbVie is committed to helping you understand all of your options for saving on HUMIRA. Just give us a call at 1.800.4HUMIRA (1.800.448.6472).

‡Restrictions apply

What you need to know about HUMIRA Citrate-free.
It's the same HUMIRA you've come to count on, plus: Learn about HUMIRA Citrate-free
 * A thinner needle
 * 50% less liquid to inject
 * A larger viewing window
 * Less pain immediately following injection*
 * Compared to HUMIRA 40 mg/0.8 mL.

In This Section

 * About HUMIRA Complete
 * Resources for You
 * Save on HUMIRA
 * Check Your Insurance Coverage
 * Insurance Explained
 * Your HUMIRA Ambassador
 * How to Inject HUMIRA
 * Sign Up for HUMIRA Complete

Already enrolled?

 * Go Straight to Your Complete Resource Center

Does your insurance cover HUMIRA?
Check Now ===IMPORTANT SAFETY INFORMATION ABOUT HUMIRA® (adalimumab)1===

What is the most important information I should know about HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
 * Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
 * Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.

What should I tell my doctor BEFORE starting HUMIRA?
Tell your doctor about all of your health conditions, including if you: Also tell your doctor about all the medicines you take. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL®(etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL®(mercaptopurine, 6-MP).
 * Have an infection, are being treated for infection, or have symptoms of an infection
 * Get a lot of infections or infections that keep coming back
 * Have diabetes
 * Have TB or have been in close contact with someone with TB, or were born in, lived in, or traveled where there is more risk for getting TB
 * Live or have lived in an area (such as the Ohio and Mississippi River valleys) where there is an increased risk for getting certain kinds of fungal infections, such as histoplasmosis, coccidioidomycosis, or blastomycosis. These infections may happen or become more severe if you use HUMIRA. Ask your doctor if you are unsure if you have lived in these areas
 * Have or have had hepatitis B
 * Are scheduled for major surgery
 * Have or have had cancer
 * Have numbness or tingling or a nervous system disease such as multiple sclerosis or Guillain-Barré syndrome
 * Have or had heart failure
 * Have recently received or are scheduled to receive a vaccine. HUMIRA patients may receive vaccines, except for live vaccines. Children should be brought up to date on all vaccines before starting HUMIRA
 * Are allergic to rubber, latex, or any HUMIRA ingredients
 * Are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed
 * Have a baby and you were using HUMIRA during your pregnancy. Tell your baby’s doctor before your baby receives any vaccines

What should I watch for AFTER starting HUMIRA?
HUMIRA can cause serious side effects, including: Call your doctor or get medical care right away if you develop any of the above symptoms.
 * Serious infections. These include TB and infections caused by viruses, fungi, or bacteria. Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle.
 * Hepatitis B infection in carriers of the virus. Symptoms include muscle aches, feeling very tired, dark urine, skin or eyes that look yellow, little or no appetite, vomiting, clay-colored bowel movements, fever, chills, stomach discomfort, and skin rash.
 * Allergic reactions. Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes, lips, or mouth.
 * Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
 * Blood problems (decreased blood cells that help fight infections or stop bleeding). Symptoms include a fever that does not go away, bruising or bleeding very easily, or looking very pale.
 * Heart failure (new or worsening). Symptoms include shortness of breath, swelling of your ankles or feet, and sudden weight gain.
 * Immune reactions including a lupus-like syndrome. Symptoms include chest discomfort or pain that does not go away, shortness of breath, joint pain, or rash on your cheeks or arms that gets worse in the sun.
 * Liver problems. Symptoms include feeling very tired, skin or eyes that look yellow, poor appetite or vomiting, and pain on the right side of your stomach (abdomen). These problems can lead to liver failure and death.
 * Psoriasis (new or worsening). Symptoms include red scaly patches or raised bumps that are filled with pus.

Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.

Remember, tell your doctor right away if you have an infection or symptoms of an infection, including:
HUMIRA is given by injection under the skin.
 * Fever, sweats, or chills
 * Muscle aches
 * Cough
 * Shortness of breath
 * Blood in phlegm
 * Weight loss
 * Warm, red, or painful skin or sores on your body
 * Diarrhea or stomach pain
 * Burning when you urinate
 * Urinating more often than normal
 * Feeling very tired

'''This is the most important information to know about HUMIRA. For more information, talk to your health care provider.'''

Uses

HUMIRA is a prescription medicine used: US-HUM-181696
 * To reduce the signs and symptoms of:
 * Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities.
 * Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. HUMIRA can be used alone, with methotrexate, or with certain other medicines.
 * Psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities.
 * Ankylosing spondylitis (AS) in adults.
 * Moderate to severe Crohn's disease (CD) and to achieve and maintain clinical remission in adults who have not responded well to certain other medications. HUMIRA is also used to reduce signs and symptoms and to achieve clinical remission in these adults who have lost response to or are unable to tolerate infliximab.
 * Moderate to severe Crohn's disease (CD) and to achieve and maintain clinical remission in children 6 years of age and older when certain other treatments have not worked well enough.
 * Moderate to severe hidradenitis suppurativa (HS) in people 12 years and older.
 * In adults, to help get moderate to severe ulcerative colitis (UC) under control (induce remission) and keep it under control (sustain remission) when certain other medicines have not worked well enough. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate anti-TNF medicines.
 * To treat moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate.
 * To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) (UV) in adults and children 2 years of age and older.

Please see the Full Prescribing Information, including the Medication Guide, for HUMIRA.

'''You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.'''

If you cannot afford your medication, contact: www.pparx.org for assistance.

[https://www.abbvie.com/privacy.html Legal Notices/Privacy Policy. Copyright 2013, AbbVie Inc., North Chicago, Illinois, U.S.A.] If you have any questions about AbbVie’s HUMIRA.com website that have not been answered click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.

Reference: 1. HUMIRA Injection [package insert]. North Chicago, IL: AbbVie Inc.

US-HUM-181640

Conditions HUMIRA Treats

 * Moderate to Severe Rheumatoid Arthritis
 * Moderate to Severe Chronic Plaque Psoriasis
 * Moderate to Severe Crohn's Disease
 * Moderate to Severe Pediatric Crohn's Disease
 * Moderate to Severe Ulcerative Colitis
 * Psoriatic Arthritis
 * Moderate to Severe Hidradenitis Suppurativa
 * Ankylosing Spondylitis
 * Moderate to Severe Polyarticular Juvenile Idiopathic Arthritis
 * Non-Infectious Intermediate, Posterior, and Panuveitis
 * About HUMIRA Complete
 * Complete Resource Center

Important Safety Information for Patients

 * Important Safety Information
 * Medication Guide
 * Full Prescribing Information
 * Información en Español

Information from AbbVie
©2013 AbbVie Inc.
 * Contact Us
 * Privacy Policy
 * Terms of Use
 * Advertising Choices
 * Health Care Professional Site